CVM
Price
$2.44
Change
-$2.07 (-45.90%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
410.58M
ONCY
Price
$0.40
Change
-$0.02 (-4.76%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
36.91M
76 days until earnings call
Interact to see
Advertisement

CVM vs ONCY

Header iconCVM vs ONCY Comparison
Open Charts CVM vs ONCYBanner chart's image
Cel-Sci
Price$2.44
Change-$2.07 (-45.90%)
Volume$9.27K
Capitalization410.58M
Oncolytics Biotech
Price$0.40
Change-$0.02 (-4.76%)
Volume$142
Capitalization36.91M
CVM vs ONCY Comparison Chart
Loading...
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVM vs. ONCY commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVM is a Hold and ONCY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (CVM: $4.51 vs. ONCY: $0.42)
Brand notoriety: CVM: Notable vs. ONCY: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVM: 27% vs. ONCY: 226%
Market capitalization -- CVM: $410.58M vs. ONCY: $36.91M
CVM [@Biotechnology] is valued at $410.58M. ONCY’s [@Biotechnology] market capitalization is $36.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVM’s FA Score shows that 0 FA rating(s) are green whileONCY’s FA Score has 0 green FA rating(s).

  • CVM’s FA Score: 0 green, 5 red.
  • ONCY’s FA Score: 0 green, 5 red.
According to our system of comparison, CVM is a better buy in the long-term than ONCY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVM’s TA Score shows that 6 TA indicator(s) are bullish while ONCY’s TA Score has 4 bullish TA indicator(s).

  • CVM’s TA Score: 6 bullish, 4 bearish.
  • ONCY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CVM is a better buy in the short-term than ONCY.

Price Growth

CVM (@Biotechnology) experienced а +1769.82% price change this week, while ONCY (@Biotechnology) price change was -18.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.05%. For the same industry, the average monthly price growth was +7.69%, and the average quarterly price growth was -1.29%.

Reported Earning Dates

CVM is expected to report earnings on May 15, 2025.

ONCY is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+5.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CVM($411M) has a higher market cap than ONCY($36.9M). CVM YTD gains are higher at: 1027.782 vs. ONCY (-53.929). CVM has higher annual earnings (EBITDA): -22.61M vs. ONCY (-34.56M). ONCY has more cash in the bank: 15.9M vs. CVM (4.61M). ONCY has less debt than CVM: ONCY (1.06M) vs CVM (11.1M). CVM (0) and ONCY (0) have equivalent revenues.
CVMONCYCVM / ONCY
Capitalization411M36.9M1,114%
EBITDA-22.61M-34.56M65%
Gain YTD1027.782-53.929-1,906%
P/E RatioN/AN/A-
Revenue00-
Total Cash4.61M15.9M29%
Total Debt11.1M1.06M1,043%
FUNDAMENTALS RATINGS
CVM vs ONCY: Fundamental Ratings
CVM
ONCY
OUTLOOK RATING
1..100
5252
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
61
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3494
P/E GROWTH RATING
1..100
49100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ONCY's Valuation (61) in the Biotechnology industry is somewhat better than the same rating for CVM (98). This means that ONCY’s stock grew somewhat faster than CVM’s over the last 12 months.

ONCY's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CVM (100). This means that ONCY’s stock grew similarly to CVM’s over the last 12 months.

ONCY's SMR Rating (100) in the Biotechnology industry is in the same range as CVM (100). This means that ONCY’s stock grew similarly to CVM’s over the last 12 months.

CVM's Price Growth Rating (34) in the Biotechnology industry is somewhat better than the same rating for ONCY (94). This means that CVM’s stock grew somewhat faster than ONCY’s over the last 12 months.

CVM's P/E Growth Rating (49) in the Biotechnology industry is somewhat better than the same rating for ONCY (100). This means that CVM’s stock grew somewhat faster than ONCY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CVMONCY
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 15 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCNUX11.12N/A
N/A
Invesco Income Advantage U.S. Fund Inv
AREEX26.45N/A
N/A
American Century Real Estate A
GACIX44.74N/A
N/A
Gabelli Small Cap Growth I
LGLCX39.69N/A
N/A
Lord Abbett Growth Leaders C
GEBNX10.77N/A
N/A
Goldman Sachs ESG Em Mkts Eq Inv

CVM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CVM has been loosely correlated with NRXS. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CVM jumps, then NRXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVM
1D Price
Change %
CVM100%
-11.74%
NRXS - CVM
58%
Loosely correlated
-19.80%
MDGL - CVM
43%
Loosely correlated
-5.30%
CYTK - CVM
40%
Loosely correlated
-4.13%
MGX - CVM
39%
Loosely correlated
-2.94%
ADXN - CVM
39%
Loosely correlated
-3.41%
More

ONCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONCY has been loosely correlated with SRRK. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ONCY jumps, then SRRK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONCY
1D Price
Change %
ONCY100%
-2.02%
SRRK - ONCY
41%
Loosely correlated
-2.60%
ABCL - ONCY
35%
Loosely correlated
-4.78%
RXRX - ONCY
32%
Poorly correlated
-10.00%
CVM - ONCY
29%
Poorly correlated
-11.74%
IMTX - ONCY
29%
Poorly correlated
-5.19%
More